Literature DB >> 16228187

[Soft tissue infections in oral, maxillofacial, and plastic surgery. Bacterial spectra and antibiotics].

A W Eckert1, P Maurer, D Wilhelms, J Schubert.   

Abstract

BACKGROUND: Soft tissue infections in the maxillofacial region are mainly caused by Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli but also by members of the genera Enterococcus, Klebsiella, and Enterobacter, respectively.
METHODS: In a prospective study 96 patients with severe maxillofacial non-odontogenic postoperative soft tissue infections were analyzed with regard to the bacterial spectrum and resistance patterns against antibiotics. The dominating bacteria were Streptococci (25% of the isolates) and Staphylococci (24% of the isolates). In addition, members of Enterobacteriaceae were isolated in approximately 10% of the cases. The most frequent anaerobes found were as follows: Peptostreptococcus, Eubacterium, Prevotella and Fusobacterium.
RESULTS: The resistance rates against antibiotics found were: penicillin G 36%, ampicillin 42%, and doxycycline 36%. In addition, the resistance rate against erythromycin and clindamycin was 26% and 7%, respectively. No resistant strains were detected against vancomycin and teicoplanin. All anaerobes showed a low antimicrobial resistance as previously described for odontogenic infections.
CONCLUSION: In summary, soft tissue infections in the maxillofacial region present a different spectrum of bacteria in contrast to the well-investigated odontogenic infections. Antibiotic administration should be, whenever possible, performed after differentiation of involved strains and resistogram. The most promising antibiotics are imipenem, meropenem, and ciprofloxacin as well as cefotiam. Modern fluoroquinolones will be the antibiotics of the future.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16228187     DOI: 10.1007/s10006-005-0645-1

Source DB:  PubMed          Journal:  Mund Kiefer Gesichtschir        ISSN: 1432-9417


  30 in total

1.  Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs.

Authors:  T Spanu; F Luzzaro; M Perilli; G Amicosante; A Toniolo; G Fadda
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999).

Authors:  A C Gales; R N Jones; K R Forward; J Liñares; H S Sader; J Verhoef
Journal:  Clin Infect Dis       Date:  2001-05-15       Impact factor: 9.079

3.  Nomenclature for aerobic and facultative bacteria.

Authors:  D A Bruckner; P Colonna
Journal:  Clin Infect Dis       Date:  1997-07       Impact factor: 9.079

4.  [In vitro activity of 9 antibiotics and 3 beta-lactamase inhibitors against 107 clinical isolates of Acinetobacter baumanii].

Authors:  M J Echeverría; M J López de Goicoechea; R Ayarza; Y Vecino; M A Lazpita; A B Ibarretxebea; A Barbier; M Cruz González; P Martínez de la Fuente
Journal:  Enferm Infecc Microbiol Clin       Date:  1997 Jun-Jul       Impact factor: 1.731

5.  Effect of different beta-lactams in combination with beta-lactamase inhibitors in the presence or absence of tobramycin against some enterobacteriaceae producing extended-spectrum beta-lactamases.

Authors:  A Ferrara; C Dos Santos; M Cimbro
Journal:  Chemotherapy       Date:  1998 Sep-Oct       Impact factor: 2.544

Review 6.  Gram-positive anaerobic cocci.

Authors:  D A Murdoch
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

7.  [Significance of antibiotic resistance in treatment of soft tissue infections].

Authors:  Ch Ruef
Journal:  Ther Umsch       Date:  2002-01

8.  In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.

Authors:  R Krause; H Mittermayer; G Feierl; F Allerberger; I Wendelin; A Hirschl; E C Reisinger
Journal:  Wien Klin Wochenschr       Date:  1999-07-30       Impact factor: 1.704

9.  Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (2000).

Authors:  Jeffrey T Kirby; Alan H Mutnick; Ronald N Jones; Douglas J Biedenbach; Michael A Pfaller
Journal:  Diagn Microbiol Infect Dis       Date:  2002-08       Impact factor: 2.803

10.  Further studies of transferable antibiotic resistance in strains of Pseudomonas aeruginosa from four clinical settings in three countries.

Authors:  J Blahová; M Hupková-Lesická; K Králiková; V Krcméry; K Kubonová; V Torsová; N Bartoníková; V Schäfer
Journal:  J Chemother       Date:  1998-06       Impact factor: 1.714

View more
  3 in total

1.  Bacterial colonization of microbial biofilms in oral squamous cell carcinoma.

Authors:  J Bolz; E Dosá; J Schubert; A W Eckert
Journal:  Clin Oral Investig       Date:  2013-06-22       Impact factor: 3.573

2.  Sonication versus the conventional method for evaluation of the dental microbiome: a prospective pilot study.

Authors:  Oliver Wagendorf; Peter Menzel; Rolf Schwarzer; Norbert Neckel; Saskia Preissner; Max Heiland; Susanne Nahles
Journal:  BMC Oral Health       Date:  2022-08-12       Impact factor: 3.747

3.  Microbiome of Odontogenic Abscesses.

Authors:  Sebastian Böttger; Silke Zechel-Gran; Daniel Schmermund; Philipp Streckbein; Jan-Falco Wilbrand; Michael Knitschke; Jörn Pons-Kühnemann; Torsten Hain; Markus Weigel; Hans-Peter Howaldt; Eugen Domann; Sameh Attia
Journal:  Microorganisms       Date:  2021-06-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.